Major cerebral events in staphylococcus aureus infective endocarditis: Is anticoagulant therapy safe?

Cardiology

Volumn 114, Issue 4, 2009, Pages 284-291

  Rasmussen, Rasmus V ^a   Snygg Martin, Ulrika ^c   Olaison, Lars ^c   Buchholtz, Kristine ^a   Larsen, Carsten T ^a   Hassager, Christian ^b   Bruun, Niels E ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticoagulation; Cerebral haemorrhage; Infective endocarditis

Indexed keywords

ANTIBIOTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BRAIN HEMORRHAGE; BRAIN INFECTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CENTRAL NERVOUS SYSTEM INFECTIONS; CEREBRAL HEMORRHAGE; DENMARK; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STROKE; SWEDEN;

EID: 68749102412     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235579     Document Type: Article

References (31)

1. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS: Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293: 3012-3021.
2. Tleyjeh IM, Steckelberg JM: Changing epidemiology of infective endocarditis. Curr Infect Dis Rep 2006; 8: 265-270.
3. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr: Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002; 162: 90-94.
4. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, Olaison L, Eykyn S, Hoen B, Abrutyn E, Raoult D, Bayer A, Fowler VG Jr: Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005; 41: 507-514. (Pubitemid 41099645)
5. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394-e434.
6. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, Soler-Soler J, Thiene G, von GA, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernandez BE, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Lekakis J, Vahanian A, et al: Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 2004; 25: 267-276. (Pubitemid 38235165)
7. Vongpatanasin W, Hillis LD, Lange RA: Prosthetic heart valves. N Engl J Med 1996; 335: 407-416.
8. Carpenter JL, McAllister CK: Anticoagulation in prosthetic valve endocarditis. South Med J 1983; 76: 1372-1375.
9. Davenport J, Hart RG: Prosthetic valve endocarditis 1976-1987: antibiotics, anticoagulation, and stroke. Stroke 1990; 21: 993-999.
10. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P: Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000; 160: 2781-2787.
11. Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J: Infective endocarditis due to Staphylococcus aureus : deleterious effect of anticoagulant therapy. Arch Intern Med 1999; 159: 473-475.
12. Buchholtz K, Larsen CT, Hassager C, Bruun NE: Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. Clin Infect Dis 2009; 48: 65-71.
13. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
14. Remadi JP, Habib G, Nadji G, Brahim A, Thuny F, Casalta JP, Peltier M, Tribouilloy C: Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg 2007; 83: 1295-1302.
15. Verhagen DW, Hermanides J, Korevaar JC, Bossuyt PM, van den Brink RB, Speelman P, van der Meer JT: Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. Arch Intern Med 2008; 168: 302-307.
16. Roder BL, Wandall DA, Espersen F, Frimodt- Moller N, Skinhoj P, Rosdahl VT: Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med 1997; 102: 379-386.
17. Hart RG, Kagan-Hallet K, Joerns SE: Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke 1987; 18: 1048-1056.
18. Snygg-Martin U, Gustafsson L, Rosengren L, Alsio A, Ackerholm P, Andersson R, Olaison L: Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008; 47: 23-30.
19. Hart RG, Foster JW, Luther MF, Kanter MC: Stroke in infective endocarditis. Stroke 1990; 21: 695-700.
20. Fowler VG Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK, Kong LK, Gottlieb G, Donovan CL, Sexton DJ, Ryan T: Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997; 30: 1072-1078.
21. Schulz R, Werner GS, Fuchs JB, Andreas S, Prange H, Ruschewski W, Kreuzer H: Clinical outcome and echocardiographic findings of native and prosthetic valve endocarditis in the 1990s. Eur Heart J 1996; 17: 281-288.
22. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, Sexton DJ, Roussakis G, Harrell LJ, Corey GR: Infective endocarditis due to Staphylococcus aureus : 59 prospectively identified cases with followup. Clin Infect Dis 1999; 28: 106-114.
23. Di SG, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, Vailloud JM, Derumeaux G, Gouvernet J, Ambrosi P, Lambert M, Ferracci A, Raoult D, Luccioni R: Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001; 37: 1069-1076.
24. Anavekar NS, Tleyjeh IM, Anavekar NS, Mirzoyev Z, Steckelberg JM, Haddad C, Khandaker MH, Wilson WR, Chandrasekaran K, Baddour LM: Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007; 44: 1180-1186.
25. Chan KL, Dumesnil JG, Cujec B, Sanfilippo AJ, Jue J, Turek MA, Robinson TI, Moher D: A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003; 42: 775-780.
26. Dickerman SA, Abrutyn E, Barsic B, Bouza E, Cecchi E, Moreno A, Doco-Lecompte T, Eisen DP, Fortes CQ, Fowler VG Jr, Lerakis S, Miro JM, Pappas P, Peterson GE, Rubinstein E, Sexton DJ, Suter F, Tornos P, Verhagen DW, Cabell CH: The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007; 154: 1086-1094.
27. Alestig K, Hogevik H, Olaison L: Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium. Scand J Infect Dis 2000; 32: 343-356.
28. Hsu RB, Chu SH: Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus . Am J Med Sci 2004; 328: 150-155.
29. Millar BC, Prendergast BD, Moore JE: Community- associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother 2008; 61: 1-7.
30. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F: Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002; 288: 75-81.
31. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, et al: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48:e1-e148.